
==== Front
Mol Ther Methods Clin Dev
Mol Ther Methods Clin Dev
Molecular Therapy. Methods & Clinical Development
2329-0501
American Society of Gene & Cell Therapy

S2329-0501(24)00151-7
10.1016/j.omtm.2024.101335
101335
Correction
An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development
Schimek Adrian
Ng Judy K.M. judy.ng@boehringer-ingelheim.com
∗
Basbas Ioannes
Martin Fabian
Xin Dongyue
Saleh David
Hubbuch Jürgen
∗ Corresponding author judy.ng@boehringer-ingelheim.com
12 9 2024
12 12 2024
12 9 2024
32 4 101335© 2024 The Author(s)
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
==== Body
pmcMain text

(Molecular Therapy: Methods & Clinical Development, 32, 101252; June 2024)

In the originally published version of this article, there was an error in the x axis description of Figure 4B. The unit was written incorrectly as kbp. In the corrected version, the unit was changed to kb. At the same time, the values of the x axis were divided by factor 1,000, so the kilo in kb could remain, and clarity is improved. The authors apologize for this error. Figure 4. VP size influence on the exclusion peak and VP sizing (corrected)

(A) SEC exclusion peak of VSV-GP and variants of different genome sizes. Normalized light scattering and radius of gyration. (B) Radius of gyration for VSV-GP (Variant 1) and larger size variants (Variants 2 to 6) over variant genome size. The radii were measured at the peak maximum of the exclusion peak (corrected).

Figure 4. VP size influence on the exclusion peak and VP sizing (original)

(A) SEC exclusion peak of VSV-GP and variants of different genome sizes. Normalized light scattering and radius of gyration. (B) Radius of gyration for VSV-GP (Variant 1) and larger size variants (Variants 2 to 6) over variant genome size. The radii were measured at the peak maximum of the exclusion peak (original).
